Russell Frank Company’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Russell Frank Company’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-36,977	Closed	-$843K	–	3086
2015 Q2	$843K	Buy	+36,977	New	+$736K	﹤0.01%	2392
2013 Q4	–	Sell	-3,653	Closed	-$53K	–	3174
2013 Q3	$53K	Buy	3,653 +2,151	+143%	+$32.9K	﹤0.01%	3086
2013 Q2	$23K	Buy	+1,502	New	+$19.8K	﹤0.01%	2985

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Russell Frank Company's MNTA Position: Q3 2015 in Review

Russell Frank Company sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2015, closing a stake of 36,977 shares — an estimated $843K sold.

Russell Frank Company first reported a position in MNTA in Q2 2013 and held it in 3 quarters. The position peaked at $843K in Q2 2015. 156 funds tracked by Wall St. Rank hold MNTA as of Q3 2015.

Russell Frank Company reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
Russell Frank Company sold 36,977 Momenta Pharmaceuticals, Inc. shares in Q3 2015, an estimated $843K.
Russell Frank Company first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 3 quarters.
Russell Frank Company's Momenta Pharmaceuticals, Inc. position peaked at $843K in Q2 2015.
156 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2015.

Based on Russell Frank Company's 13F filing for Q3 2015, filed 23 Oct 2015.